Evidence map›Paper›PMID 24037939›Full record

ArticleLasers in surgery and medicine2013

Increased nanoparticle-loaded exogenous macrophage migration into the brain following PDT-induced blood-brain barrier disruption.

Steen J Madsen, H Michael Gach, Seok Jin Hong, Francisco A Uzal, Qian Peng, Henry Hirschberg

Open access · bronzeAbstract readEvaluation Study
In one paragraph

Article in Lasers in surgery and medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 47 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Recent progress of macrophage vesicle-based drug delivery systems.Drug delivery and translational research · 2022
    Review
  8. Review
  9. Article
  10. Functional Polymer Nanocarriers for Photodynamic Therapy.Pharmaceuticals (Basel, Switzerland) · 2018
    Review
  11. Article
  12. Photodynamic therapy mediated immune therapy of brain tumors.Neuroimmunology and neuroinflammation · 2018
    Article
  13. Photodynamic opening of blood-brain barrier.Biomedical optics express · 2017
    Article
  14. Cell Mediated Photothermal Therapy of Brain Tumors.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2017
    Review
  15. Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 6 institutions in 3 countries.

Steen J MadsenDepartment of Health Physics and Diagnostic Sciences, University of Nevada, Las Vegas, Nevada, 89154.
H Michael Gach
Seok Jin Hong
Francisco A Uzal
Qian Peng
Henry Hirschberg
Oslo University Hospital · NOSungkyunkwan University · KRUniversity of California, Davis · USUniversity of California, Irvine · USUniversity of Nevada, Las Vegas · USUniversity of Pittsburgh · US

Funding

WOUND MIGRATION FORCE MONITORINGP41RR001192 · NCRR · UNIVERSITY OF CALIFORNIA-IRVINE · PI LYUBOVITSKY, JULIA · 1985 to 2011
$14.2M
Virtual Photonocs TechnologiesP41EB015890 · NIBIB · UNIVERSITY OF CALIFORNIA-IRVINE · PI DURKIN, ANTHONY J · 2012 to 2017
$7.0M
NCRR NIH HHS P41 RR001192NIBIB NIH HHS P41 EB015890NIBIB NIH HHS P41EB015890
6 · The paper itself

Abstract

BACKGROUND AND

objectivePhotodynamic therapy (PDT)-induced disruption of the blood-brain barrier (BBB) has been investigated as a technique for the delivery of therapeutic agents to selective regions of the brain. The purpose of this study was to determine the effects of PDT on the migration of systemically administered exogenous macrophages (Ma) loaded with iron oxide nanoparticles in non-tumor bearing rats. MATERIALS AND

methodsA control group consisting of three Sprague-Dawley rats was injected with iron oxide-loaded rat alveolar Ma via jugular vein catheter while two animals were subjected to intracranial injection of iron oxide-loaded Ma. PDT-treated animals were injected with photosensitizer (AlPcS2a ; 1 mg/kg i.p.) followed by light irradiation (wavelength = 670 nm; light dose = 2.5 J) 48 hours later. Light irradiation was performed through the skull. Prior to light irradiation, iron oxide-loaded Ma were administered to each animal. Animals in all groups were imaged in a 7 Tesla (T) magnetic resonance (MR) imager to determine the extent of PDT-induced edema and to evaluate for the presence of iron oxide nanoparticles. Animals were sacrificed 7 days post-Ma administration and their brains analyzed for the presence of iron oxide using Perls staining.

resultsSignificant uptake of iron oxide nanoparticles by rat alveolar Ma was observed thus providing the rationale for their use as delivery vectors. Histopathological analyses failed to find evidence of iron oxide in normal rat brain. Accumulations of iron oxide-loaded Ma were observed in both MR images and histological sections of non-tumor bearing rat brain following PDT-induced disruption of the BBB.

conclusionsMR imaging was shown to be useful for localizing iron-oxide loaded Ma in rat brains. Exogenous Ma are incapable of traversing the normal BBB and therefore, the use of Ma as delivery vehicles into the brain requires selective disruption of the BBB.

Indexed as

AnimalsBlood-Brain BarrierCell Migration Assays, MacrophageContrast MediaDextransIndolesMacrophages, AlveolarMagnetic Resonance ImagingMagnetite NanoparticlesMaleOrganometallic CompoundsPhotochemotherapyPhotosensitizing AgentsRatsRats, Sprague-Dawleyaluminum phthalocyanine disulfonateContrast MediaDextransferumoxidesIndolesMagnetite NanoparticlesOrganometallic CompoundsPhotosensitizing Agentsgliomairon oxide nanoparticlesmagnetic resonance imagingphotodynamic therapy

Identifiers

PMID24037939
PMCPMC4026156
OpenAlexW1532711335

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.